120 related articles for article (PubMed ID: 12619438)
21. Seroprevalence of mumps before inclusion of mumps vaccination in the Iranian expanded programme on immunization.
Avijgan M; Habibian R; Kheiri S
East Mediterr Health J; 2009; 15(2):295-301. PubMed ID: 19554975
[TBL] [Abstract][Full Text] [Related]
22. Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants.
Spoulou V; Giannaki M; Vounatsou M; Bakoula C; Grafakos S
Bone Marrow Transplant; 2004 Jun; 33(12):1187-90. PubMed ID: 15077129
[TBL] [Abstract][Full Text] [Related]
23. Evidence for a recent decrease in measles susceptibility among young American adults.
Smoak BL; Novakoski WL; Mason CJ; Erickson RL
J Infect Dis; 1994 Jul; 170(1):216-9. PubMed ID: 8014503
[TBL] [Abstract][Full Text] [Related]
24. Cellular immunity to mumps virus in young adults 21 years after measles-mumps-rubella vaccination.
Jokinen S; Osterlund P; Julkunen I; Davidkin I
J Infect Dis; 2007 Sep; 196(6):861-7. PubMed ID: 17703416
[TBL] [Abstract][Full Text] [Related]
25. Measles transmission and vaccine effectiveness during a large outbreak on a densely populated island: implications for vaccination policy.
Marin M; Nguyen HQ; Langidrik JR; Edwards R; Briand K; Papania MJ; Seward JF; LeBaron CW
Clin Infect Dis; 2006 Feb; 42(3):315-9. PubMed ID: 16392073
[TBL] [Abstract][Full Text] [Related]
26. Serosurvey of measles, mumps and rubella antibodies in Saudi children.
Al-Mazrou YY; Khalil MK; Tischer A; Al-Jeffri MH; Al-Ghamdi YS; Bakhsh MM; Mishkas AA; Elgizouli SA
Saudi Med J; 2005 Oct; 26(10):1551-4. PubMed ID: 16228054
[TBL] [Abstract][Full Text] [Related]
27. An outbreak of measles among unvaccinated young adults and measles seroprevalence study: implications for measles outbreak control in adult populations.
Ehresmann KR; Crouch N; Henry PM; Hunt JM; Habedank TL; Bowman R; Moore KA
J Infect Dis; 2004 May; 189 Suppl 1():S104-7. PubMed ID: 15106098
[TBL] [Abstract][Full Text] [Related]
28. Population immunity to measles in the United States, 1999.
Hutchins SS; Bellini WJ; Coronado V; Jiles R; Wooten K; Deladisma A
J Infect Dis; 2004 May; 189 Suppl 1():S91-7. PubMed ID: 15106096
[TBL] [Abstract][Full Text] [Related]
29. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
Janaszek-Seydlitz W; Bucholc B; Wysokińska T; Górska P; Gniadek G
Przegl Epidemiol; 2003; 57(2):281-8. PubMed ID: 12910596
[TBL] [Abstract][Full Text] [Related]
30. Seroprevalence of measles- and rubella-specific antibodies among military recruits, Canada, 1991.
Duclos P; Tepper ML; Weber J; Marusyk RG
Can J Public Health; 1994; 85(4):278-81. PubMed ID: 7987753
[TBL] [Abstract][Full Text] [Related]
31. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
Lieberman JM; Williams WR; Miller JM; Black S; Shinefield H; Henderson F; Marchant CD; Werzberger A; Halperin S; Hartzel J; Klopfer S; Schödel F; Kuter BJ;
Pediatr Infect Dis J; 2006 Jul; 25(7):615-22. PubMed ID: 16804432
[TBL] [Abstract][Full Text] [Related]
32. [Measles antibodies concentration in vaccinated children and adolescents with autoimmune hepatitis].
Szenborn L; Kacprzak-Bergman I; Zaleska I; Gruszka J
Pol Merkur Lekarski; 2004 Oct; 17(100):326-30. PubMed ID: 15690693
[TBL] [Abstract][Full Text] [Related]
33. Mumps in Poland since 1990 to 2003; epidemiology and antibody prevalence.
Janaszek-Seydlitz W; Bucholc B; Gorska P; Slusarczyk J
Vaccine; 2005 Apr; 23(21):2711-6. PubMed ID: 15780717
[TBL] [Abstract][Full Text] [Related]
34. Assessment of the potency and potential immunomodulatory effects of the measles mumps rubella and varicella vaccine in infants.
Yerkovich ST; Rowe J; Richmond P; Suriyaarachchi D; Heaton T; Hollams E; Ladyman C; Serralha M; Sadowska A; Loh R; Wesselingh SL; Sly PD; Holt PG
Vaccine; 2007 Feb; 25(10):1764-70. PubMed ID: 17224218
[TBL] [Abstract][Full Text] [Related]
35. Atopic dermatitis is increased following vaccination for measles, mumps and rubella or measles infection.
Olesen AB; Juul S; Thestrup-Pedersen K
Acta Derm Venereol; 2003; 83(6):445-50. PubMed ID: 14690341
[TBL] [Abstract][Full Text] [Related]
36. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up.
Davidkin I; Jokinen S; Broman M; Leinikki P; Peltola H
J Infect Dis; 2008 Apr; 197(7):950-6. PubMed ID: 18419470
[TBL] [Abstract][Full Text] [Related]
37. Influence of MMR-vaccinations and diseases on atopic sensitization and allergic symptoms in Swiss schoolchildren.
Roost HP; Gassner M; Grize L; Wüthrich B; Sennhauser FH; Varonier HS; Zimmermann H; Braun-Fahrländer Ch;
Pediatr Allergy Immunol; 2004 Oct; 15(5):401-7. PubMed ID: 15482514
[TBL] [Abstract][Full Text] [Related]
38. Girls may have lower levels of maternal measles antibodies and higher risk of subclinical measles infection before the age of measles vaccination.
Martins C; Bale C; Garly ML; Rodrigues A; Lisse IM; Andersen A; Eriksson M; Benn CS; Whittle H; Aaby P
Vaccine; 2009 Aug; 27(38):5220-5. PubMed ID: 19596409
[TBL] [Abstract][Full Text] [Related]
39. Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine.
Ovsyannikova IG; Pankratz VS; Vierkant RA; Jacobson RM; Poland GA
J Infect Dis; 2006 Mar; 193(5):655-63. PubMed ID: 16453260
[TBL] [Abstract][Full Text] [Related]
40. Age-specific mumps seroprevalence of an unvaccinated population of adolescents in Ankara, Turkey.
Kanbur NO; Derman O; Kutluk T
Jpn J Infect Dis; 2003; 56(5-6):213-5. PubMed ID: 14695433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
